{"createdAt":"8/2/2020, 2:43:03 PM","timestamp":1596393783509,"Company ID number":"747","DMX_ISSUER_NAME":"SICHUAN LANGUANG DEVELOPMENT CO., LTD.","DMX_ISSUER_ID":"IID000000002133661","Country of Classification":"CHINA","name":"Sichuan Languang Development Co Ltd ","code":"600466","stock_exchange":"Shanghai Stock Exchange","people":[{"id":"四川蓝光发展股份有限公司_杨铿","group":"board","name":"杨铿","title":"董事长,董事","isMale":true,"age":"59","degree":"硕士","salary":"492.0万","stockAmount":"3.475亿","description":"杨铿,男,1961年出生,中国籍,拥有新加坡境外居留权,硕士研究生学历。1984年7月至1987年12月,历任成都工程机械集团上游机械厂工段长、车间主任、副厂长;1987年12月至1991年9月,任成都兰光汽配有限公司总经理;1991年9月至今,担任蓝光集团董事局主席、蓝光和骏董事长、蓝光发展董事长。现任全国政协委员,全国工商联常委,四川省人大代表,中国房地产业协会副会长,成都市房地产业协会会长。","lastUpdated":"2018-04-21"},{"id":"四川蓝光发展股份有限公司_迟峰","group":"board","name":"迟峰","title":"副董事长,董事","isMale":true,"age":"47","degree":"硕士","salary":"18.95万","stockAmount":"182.1万","description":"迟峰先生,男,1973年出生,持有吉林大学国际经济法学学士学位及中欧国际工商学院EMBA学位。1999年加入华润(集团)有限公司,历任华润(上海)有限公司副总经理、华润新鸿基房地产(无锡)有限公司总经理,2011年至2013年任华润置地有限公司副总裁兼江苏大区总经理,2013年起任华润置地有限公司高级副总裁(一级利润中心总经理级),先后兼任江苏大区总经理、华东大区总经理、物业总公司董事长。现任四川蓝光发展股份有限公司总裁(法定代表人)。于2020年6月11日获委任为四川蓝光嘉宝服务集团股份有限公司非执行董事。","lastUpdated":"2020-05-16"},{"id":"四川蓝光发展股份有限公司_欧俊明","group":"board","name":"欧俊明","title":"董事","isMale":true,"age":"51","degree":"","salary":"286.0万","stockAmount":"539.8万","description":"欧俊明先生,审计师、会计师、中国注册会计师、注册评估师,国际内部审计师。曾任广东省审计厅直属分局科员、外资审计处科员,广东省华粤会计师事务所业务三部经理,越秀(集团)有限公司监察稽核室副总经理,越秀集团审计室总经理,越投城建财务部总经理,越秀集团、越秀企业(集团)有限公司财务部总经理,广州造纸集团有限公司、广州造纸股份有限公司监事,广州越银实业投资有限公司董事、总经理、法定代表人,广州证券股份有限公司监事会召集人,广州越秀产业投资基金管理股份有限公司监事会主席,广州越秀融资租赁有限公司董事。越秀集团、越秀企业(集团)有限公司、广州越秀企业集团有限公司首席风控官,审计部、管理部、信息中心总经理,广州越秀金融控股集团股份有限公司董事,广州越秀金融金控集团有限公司董事,越秀金融控股有限公司非执行董事,广州市城市建设开发有限公司董事,越秀地产股份有限公司执行董事、财务总监,越秀证券控股有限公司董事。现任四川蓝光发展股份有限公司首席财务官(财务负责人)兼四川蓝光和骏实业有限公司首席财务官。","lastUpdated":"2018-04-21"},{"id":"四川蓝光发展股份有限公司_余驰","group":"board","name":"余驰","title":"董事","isMale":true,"age":"37","degree":"硕士","salary":"315.0万","stockAmount":"884万","description":"余驰先生,韩国国际法律经营大学院硕士研究生学历,注册执业律师。历任四川蓝光和骏实业有限公司成都公司总经理、成都区域董事总经理、投资副总裁。现任四川蓝光发展股份有限公司首席运营官,四川蓝光和骏实业有限公司董事、常务副总裁。于2020年6月11日获委任为四川蓝光嘉宝服务集团股份有限公司非执行董事。","lastUpdated":"2018-09-21"},{"id":"四川蓝光发展股份有限公司_孟宏伟","group":"board","name":"孟宏伟","title":"董事","isMale":true,"age":"46","degree":"本科","salary":"258.0万","stockAmount":"241.6万","description":"孟宏伟先生，于2018年11月23日获委任为四川蓝光嘉宝服务集团股份有限公司非执行董事。孟先生主要负责就集团的整体发展提供指导。自1997年7月至2008年4月，孟先生担任华为技术有限公司的副主任。自2008年4月至2015年3月，孟先生担任新世界（中国）地产投资有限公司湖南地区总监助理。孟先生于2015年6月加入蓝光发展，并先后担任蓝光和骏人力资源中心总经理、以及该公司的总裁助理及行政副总裁，负责人力资源和行政的整体管理。孟先生目前担任蓝光发展的董事兼首席人力资源官、蓝光和骏的董事兼行政副总裁、成都迪康药业股份有限公司的董事及成都炫锦企业管理有限公司的法定代表人、执行董事兼总经理。孟先生于1997年7月毕业于中国的中国人民大学，修读完劳动经济学课程。","lastUpdated":"2019-01-24"},{"id":"四川蓝光发展股份有限公司_杨武正","group":"board","name":"杨武正","title":"董事","isMale":true,"age":"25","degree":"硕士","salary":"--","stockAmount":"-","description":"杨武正先生,男,现年25岁,硕士学历,持有美国德雷塞尔大学金融本科学历和英国华威大学金融硕士学历。曾任蓝光投资控股集团有限公司董事、董事长助理。现任蓝光投资控股集团有限公司董事,四川蓝光发展股份有限公司董事长助理兼投资发展中心副总经理。","lastUpdated":"2020-05-16"},{"id":"四川蓝光发展股份有限公司_唐小飞","group":"board","name":"唐小飞","title":"独立董事","isMale":true,"age":"46","degree":"博士","salary":"20.00万","stockAmount":"-","description":"唐小飞先生,1974年5月出生,毕业于西南交通大学,教授,博士生导师。现任西南财经大学西部商学院教授、博士生导师,西南财经大学城市品牌战略研究所所长,教育部新世纪优秀人才,兼任国际品牌战略学会秘书长兼常务理事、中国市场学会理事、阿佩克思&奥美品牌营销咨询有限公司顾问、成都市政府品牌发展专家顾问、成都市驰名商标评审委员会专家、央视微电影青春频道执行总监,四川蓝光发展股份有限公司独立董事。","lastUpdated":"2018-04-21"},{"id":"四川蓝光发展股份有限公司_王晶","group":"board","name":"王晶","title":"独立董事","isMale":true,"age":"39","degree":"博士","salary":"20.00万","stockAmount":"-","description":"王晶先生,法学博士,毕业于美国耶鲁大学和美国哈佛大学法学院,获历史学学士学位及法学博士学位,并于2007年取得美国纽约州律师执照。在耶鲁大学时期曾获得Sterling学者荣誉,在哈佛法学院深造期间荣获公益项目奖学金。曾在联合国卢旺达国际刑事法庭检察官办公室实习,后在美国苏利文克伦威尔律师事务所纽约及北京办公室担任律师。曾参与的项目获得由专业权威杂志《CHINABUSINESSLAW》评选的2012年度最佳并购奖及最佳海外上市奖。现任佳辰资本有限公司法务总监,四川蓝光发展股份有限公司第六届董事会独立董事。","lastUpdated":"2018-04-21"},{"id":"四川蓝光发展股份有限公司_逯东","group":"board","name":"逯东","title":"独立董事","isMale":true,"age":"38","degree":"博士","salary":"20.00万","stockAmount":"-","description":"逯东,男,38岁,博士,西南财经大学会计学院教授。主要工作经历如下:2010.07--2012.06在西南财经大学中国家庭金融调查与研究中心担任讲师;2012.07--2012.12在西南财经大学会计学院担任讲师;2013.01--至今历任西南财经大学会计学院副教授、教授、于2014年参加上海证券交易所独立董事资格培训,并取得独立董事资格证书。","lastUpdated":"2018-04-21"},{"id":"四川蓝光发展股份有限公司_王小英","group":"supervisoryCommittee","name":"王小英","title":"监事会主席","isMale":false,"age":"47","degree":"硕士","salary":"272.0万","stockAmount":"197.2万","description":"王小英女士,西南财经大学EMBA学历,中国注册会计师、中国注册资产评估师。曾就职于四川乐山东风电机厂,2001年10月入职蓝光投资控股集团有限公司,历任蓝光投资控股集团有限公司及下属子公司监察审计部副总监、总经理,蓝光投资控股集团有限公司监事、副董事长,原四川迪康科技药业股份有限公司第五届监事会主席。现任蓝光投资控股集团有限公司董事兼总经理,四川蓝光发展股份有限公司第六届监事会主席,兼任四川蓝光和骏实业有限公司监事会主席。","lastUpdated":"2018-04-21"},{"id":"四川蓝光发展股份有限公司_蒋淑萍","group":"supervisoryCommittee","name":"蒋淑萍","title":"监事","isMale":false,"age":"41","degree":"本科","salary":"37.26万","stockAmount":"-","description":"蒋淑萍女士,现年41岁,本科学历,毕业于西南财经大学,会计师。曾就职于新都化工股份有限公司(云图控股002539)。2007年4月入职蓝光商业集团,历任嘉宝股份、蓝光商业集团财务经理、财务总经理;四川蓝光和骏实业有限公司审计总监、蓝光商业集团总裁助理兼审计总经理。现任蓝光投资控股集团有限公司财务总经理。","lastUpdated":"2019-12-04"},{"id":"四川蓝光发展股份有限公司_雷鹏","group":"supervisoryCommittee","name":"雷鹏","title":"职工监事","isMale":true,"age":"39","degree":"硕士","salary":"109.9万","stockAmount":"97.9万","description":"雷鹏先生,研究生学历,毕业于西南财经大学法学专业。曾任成都市中级人民法院助理审判员。2014年1月起历任四川蓝光和骏实业有限公司公司高级法务经理、审计法务中心法律事务部副主任,兼任四川蓝光和骏实业有限公司董事。现任四川蓝光发展股份有限公司第六届监事会职工代表监事,四川蓝光发展股份有限公司总裁助理,兼任审计法务中心法律事务部主任。","lastUpdated":"2018-03-31"},{"id":"四川蓝光发展股份有限公司_迟峰","group":"manager","name":"迟峰","title":"总裁","isMale":true,"age":"47","degree":"硕士","salary":"18.95万","stockAmount":"182.1万","description":"迟峰先生,男,1973年出生,持有吉林大学国际经济法学学士学位及中欧国际工商学院EMBA学位。1999年加入华润(集团)有限公司,历任华润(上海)有限公司副总经理、华润新鸿基房地产(无锡)有限公司总经理,2011年至2013年任华润置地有限公司副总裁兼江苏大区总经理,2013年起任华润置地有限公司高级副总裁(一级利润中心总经理级),先后兼任江苏大区总经理、华东大区总经理、物业总公司董事长。现任四川蓝光发展股份有限公司总裁(法定代表人)。于2020年6月11日获委任为四川蓝光嘉宝服务集团股份有限公司非执行董事。","lastUpdated":"2020-05-16"},{"id":"四川蓝光发展股份有限公司_罗瑞华","group":"manager","name":"罗瑞华","title":"董事会秘书,副总裁","isMale":true,"age":"43","degree":"硕士","salary":"230.0万","stockAmount":"246.5万","description":"罗瑞华先生,复旦大学硕士研究生学历。历任上海世茂股份有限公司董事会秘书,银亿房地产股份有限公司董事会秘书,阳光城集团股份有限公司董事会秘书。现任四川蓝光发展股份有限公司副总裁、董事会秘书。","lastUpdated":"2018-08-25"},{"id":"四川蓝光发展股份有限公司_欧俊明","group":"manager","name":"欧俊明","title":"首席财务官","isMale":true,"age":"51","degree":"","salary":"286.0万","stockAmount":"539.8万","description":"欧俊明先生,审计师、会计师、中国注册会计师、注册评估师,国际内部审计师。曾任广东省审计厅直属分局科员、外资审计处科员,广东省华粤会计师事务所业务三部经理,越秀(集团)有限公司监察稽核室副总经理,越秀集团审计室总经理,越投城建财务部总经理,越秀集团、越秀企业(集团)有限公司财务部总经理,广州造纸集团有限公司、广州造纸股份有限公司监事,广州越银实业投资有限公司董事、总经理、法定代表人,广州证券股份有限公司监事会召集人,广州越秀产业投资基金管理股份有限公司监事会主席,广州越秀融资租赁有限公司董事。越秀集团、越秀企业(集团)有限公司、广州越秀企业集团有限公司首席风控官,审计部、管理部、信息中心总经理,广州越秀金融控股集团股份有限公司董事,广州越秀金融金控集团有限公司董事,越秀金融控股有限公司非执行董事,广州市城市建设开发有限公司董事,越秀地产股份有限公司执行董事、财务总监,越秀证券控股有限公司董事。现任四川蓝光发展股份有限公司首席财务官(财务负责人)兼四川蓝光和骏实业有限公司首席财务官。","lastUpdated":"2018-04-21"}],"companyName":"四川蓝光发展股份有限公司","province":"四川省","englishName":"Sichuan Languang Development Co Ltd","industry":"房地产 — 房地产开发Ⅱ","website":"www.brc.com.cn","mainBusiness":"房地产开发业务","productsName":["住宅及配套","商业地产","现代服务业","医药"],"actualController":"杨铿","actualControllerSharePercentage":"55.99%","registeredCapital":"30.35亿元","employeeAmount":"17378","phone":"86-028-87826466","location":"四川省成都市郫都区高新区(西区)西芯大道9号,上海市虹桥枢纽褚光路1588弄虹桥世界中心D1栋","chineseDescription":"四川蓝光发展股份有限公司专注于房地产开发和经营，公司的主要产品及服务为住宅及配套、商业地产、现代服务业、医药。产品品牌“雍锦系”2019年荣获“中国优秀社区服务项目TOP10”（数据来源：亿翰智库），并荣获“2019年品质美宅产品系TOP10”（数据来源：易居克而瑞研究中心）；“芙蓉系”荣获“2019中国房地产优秀原创产品品牌TOP1”(数据来源：中国指数研究院),另荣获“2019中国房企产品品牌TOP1”（数据来源：亿翰智库）；“黑钻系”荣获“2019中国房地产精品项目品牌价值TOP10”(数据来源：中国指数研究院)；“长岛系”荣膺“2019中国百城建筑新地标”（数据来源：中国指数研究院）。...查看全部▼四川蓝光发展股份有限公司专注于房地产开发和经营，公司的主要产品及服务为住宅及配套、商业地产、现代服务业、医药。产品品牌“雍锦系”2019年荣获“中国优秀社区服务项目TOP10”（数据来源：亿翰智库），并荣获“2019年品质美宅产品系TOP10”（数据来源：易居克而瑞研究中心）；“芙蓉系”荣获“2019中国房地产优秀原创产品品牌TOP1”(数据来源：中国指数研究院),另荣获“2019中国房企产品品牌TOP1”（数据来源：亿翰智库）；“黑钻系”荣获“2019中国房地产精品项目品牌价值TOP10”(数据来源：中国指数研究院)；“长岛系”荣膺“2019中国百城建筑新地标”（数据来源：中国指数研究院）。公司连续13年上榜中国房地产综合实力百强,名列第21位,位列百强房企成长性第4位;连续5年荣膺中国十大最具投资价值上市房企,排名第4位;连续4年荣获“中国房地产公司品牌价值TOP10(混合所有)”殊荣,排名第5位。收起▲","foundedDate":"1993-05-18","goPublicDate":"2001-02-12","companyHistory":"四川蓝光发展股份有限公司（原四川迪康科技药业股份有限公司。以下简称公司或本公司）前身系成都迪康制药公司，公司成立于1993年5月，后经1997年7月和1999年5月两次股权转让、1998年9月增资扩股并更名为成都迪康制药有限公司。1999年12月17日，经四川省体改委川经体改﹝1999﹞101号文批准、四川省人民政府川府函﹝2000﹞19号确认，成都迪康制药有限公司整体变更为四川迪康科技药业股份有限公司。\n　　2001年2月，经中国证监会证监发字﹝2001﹞11号文审核批准，公司50,000,000股人民币普通股获准在上海证券交易所挂牌上市交易。\n　　2008年6月，蓝光投资控股集团有限公司（原四川蓝光实业集团有限公司，以下简称蓝光集团）通过司法拍卖竞得四川迪康产业控股集团股份有限公司持有的公司限售流通股52,510,000股，成为公司控股股东，占公司总股本的29.90%。\n　　2011年4月11日，公司以2010年末总股本175,602,342股为基数，以资本公积每10股转增15股，共计转增263,403,513股，转增后公司股本总额为439,005,855.00元，折合股份439,005,855股(每股面值1元)。\n　　截至2014年12月31日，公司注册资本439,005,855.00元，股份总数439,005,855股(每股面值1元)，均为无限售条件的流通股股份。其中蓝光集团持有公司股份61,350,600股，占公司总股本的13.97%。\n　　根据四川迪康科技药业股份有限公司董事会和股东大会审议通过的决议案，并经中国证监会核准，四川迪康科技药业股份有限公司通过向特定对象发行股份的方式，购买了母公司蓝光集团所持有的四川蓝光和骏实业股份有限公司（该公司系四川蓝光和骏实业股份有限公司根据四川蓝光和骏实业股份有限公司2013年第十七次临时股东大会决议进行分立后的存续公司，已于2015年3月26日更名为四川蓝光和骏实业有限公司，以下简称蓝光和骏公司）75.31%股份、深圳市平安创新资本投资有限公司持有的蓝光和骏公司16.44%股份和杨铿先生持有的蓝光和骏公司8.25%股份；四川蓝光和骏实业股份有限公司以2015年2月28日为股权交割基准日整体并入四川迪康科技药业股份有限公司。同时，四川迪康科技药业股份有限公司已向四川产业振兴发展投资基金有限公司等7名特定投资者非公开发行人民币普通股（A股）募集本次重组的配套资金，于2015年4月14日完成非公开发行人民币普通股（A股）股票。并于2015年5月6日完成工商登记变更。\n　　四川迪康科技药业股份有限公司于2015年4月13日经核准更名为四川蓝光发展股份有限公司。\n　　2015年12月，经本公司第六届董事会第十七次会议和2015年第十一次临时股东大会审议通过《四川蓝光发展股份有限公司限制性股票激励计划（草案）及其摘要的议案》，本公司以定向发行新股方式，增加注册资本19,088,300.00元。\n　　本公司于2016年2月17日取得成都市工商行政管理局核发的变更后的企业法人营业执照，统一社会信用代码：915101007092429550；公司名称：四川蓝光发展股份有限公司；公司类型：\n　　其他股份有限公司（上市）；公司住所：成都高新区（西区）西芯大道9号；法定代表人：张志成；注册资本：（人民币）贰拾壹亿叁仟陆佰壹拾万零陆仟叁佰叁拾玖元。\n　　本公司之母公司为蓝光集团，最终控制人为杨铿。\n　　2017年6月，根据本公司第六届董事会第四十五次会议审议通过的《关于回购注销部分激励对象已获授但尚未解锁的限制性股票的议案》，本公司回购注销部分激励对象已获授但尚未解锁的限制性股票922,000股，减少注册资本922,000.00元。\n　　2017年12月，根据本公司第六届董事会第五十四次会议审议通过的《关于回购注销部分激励对象已获授但尚未解锁的限制性股票的议案》，本公司回购注销部分激励对象已获授但尚未解锁的限制性股票2,077,400股，减少注册资本2,077,400.00元。\n　　2018年5月，根据本公司第六届董事会第五十八次会议和2017年年度股东大会审议通过审议通过的《关于回购注销部分激励对象已获授但尚未解锁的限制性股票的议案，本公司回购注销部分激励对象已获授但尚未解锁的限制性股票491,400股，减少注册资本491,400元。\n　　2018年6月，本公司以2017年度利润分配方案实施前的总股本2,131,728,339股为基数，以资本公积每10股转增4股，共计转增852,691,336股，转增后本公司股本总额为2,984,419,675股。\n　　2018年12月，根据本公司第七届董事会第十一次会议审议通过《关于回购注销部分激励对象已获授但尚未解锁的限制性股票的议案》，本公司回购注销部分激励对象已获授但尚未解锁的限制性股票311,640股，减少注册资本311,640.00元。\n　　2019年4月2日,本公司召开第七届董事会第二十次会议审议通过《关于公司2018年股票期权激励计划首次授予及预留授予股票期权第一个行权期符合行权条件的议案》,根据本公司股票期权激励计划、《四川蓝光发展股份有限公司2018年股票期权激励计划实施考核管理办法》的相关规定及股东大会的授权,董事会认为本公司2018年股票期权激励计划首次授予及预留授予的股票期权第一个行权期行权条件已经达成。截至本年末,股票期权激励对象行权增加本公司股本28,408,000股。收起▲","shareholders":[{"organizationId":"T000252600","holderName":"蓝光投资控股集团有限公司","totalShare":"14.22亿","sharePercentage":"47.21%"},{"organizationId":"","holderName":"杨铿","totalShare":"3.47亿","sharePercentage":"11.54%"},{"organizationId":"T000073058","holderName":"中国证券金融股份有限公司","totalShare":"8943.94万","sharePercentage":"2.97%"},{"organizationId":"T000125370","holderName":"香港中央结算有限公司","totalShare":"3793.36万","sharePercentage":"1.26%"},{"organizationId":"","holderName":"中国人民人寿保险股份有限公司-传统-普通保险产品","totalShare":"2911.43万","sharePercentage":"0.97%"},{"organizationId":"","holderName":"中国人民财产保险股份有限公司-传统-收益组合","totalShare":"1809.09万","sharePercentage":"0.60%"},{"organizationId":"","holderName":"招商银行股份有限公司-中欧恒利三年定期开放混合型证券投资基金","totalShare":"1550.95万","sharePercentage":"0.51%"},{"organizationId":"","holderName":"中国农业银行股份有限公司-中证500交易型开放式指数证券投资基金","totalShare":"1481.60万","sharePercentage":"0.49%"},{"organizationId":"","holderName":"肖益群","totalShare":"1427.00万","sharePercentage":"0.47%"},{"organizationId":"","holderName":"张巧龙","totalShare":"1390.59万","sharePercentage":"0.46%"}],"englishDescription":"SICHUAN LANGUANG DEVELOPMENT CO., LTD. mainly operates business through real estate development and operation, modern service industry, 3 dimension (3D) bio-printing and medical segment. The Real Sstate Development & Operation segment has more than 100 development projects in nearly 20 cities in China. The Modern Service Industry segment provides property service based modern services through the subsidiary, Sichuan JUSTBON Asset Management Group Co., Ltd. The 3D Bio-printing segment is involved in the application of 3D bio-printing technology through the subsidiary, Sichuan Revotek Bio-technology Co., Ltd. The Medical segment is involved in the research and development, production and sales of medicine and medical instruments through the subsidiary, Chengdu Dikang Pharmaceutical Co., Ltd. ","englishIndustry":"Construction Services","Price to earnings (ttm)":"5.27","Price to sales (ttm)":"0.42","Price to book (mrq)":"0.81","Price to cash flow (ttm)":"--","Total debt to equity (mrq)":"338.34","Lt debt to equity (mrq)":"204.49","Return on investment (ttm)":"6.85","Return on equity (ttm)":"2.25","Income statement":{},"Balance sheet":{},"Cash flow":{"Cash receipts":"55,500.27","Cash payments":"(39,462.04)","Cash taxes paid":"(5,387.42)","Changes in working capital":"(6,817.45)","Cash from operating activities":"3,833.35","Capital expenditures":"(272.40)","Other investing cash flow items, total":"(9,379.62)","Cash from investing activities":"(9,652.02)","Financing cash flow items":"11,329.13","Total cash dividends paid":"(6,239.33)","Issuance (retirement) of debt, net":"1,876.11","Cash from financing activities":"6,965.90","Foreign exchange effects":"4.89","Net change in cash":"1,152.12"},"keyMetrics":{"Price and Volume":{"Price closing or last bid":"5.35","52 Week High":"7.75","52 Week Low":"5.00","Pricing date":"","10 Day Average Trading Volume":"23.83","Market Capitalization":"16,236.88","52 Week High Date":"","52 Week Low Date":"","3 Month Average Trading Volume":"697.97","Beta":"1.10","1 Day Price Change":"0.19","13 Week Price Return (Daily)":"-8.08","26 Week Price Return (Daily)":"-22.13","5 Day Price Return (Daily)":"-0.37","52 Week Price Return (Daily)":"-10.68","Year To Date Price Return (Daily)":"-27.41","Month to Date Price Return (Daily)":"-0.74","Price Relative to S&P500 (4 Week)":"-15.21","Price Relative to S&P500 (13 Week)":"-20.57","Price Relative to S&P500 (26 Week)":"-29.97","Price Relative to S&P500 (52 Week)":"-21.51","Price Relative to S&P500 (YTD)":"-33.11"},"Per Share Data":{"EPS excl. Extra Items (Annual)":"1.02","EPS excl. Extra Items (TTM)":"1.01","EPS Normalized (Annual)":"1.10","Revenue per Share (Annual)":"12.64","Revenue per Share (TTM)":"11.78","Book Value (Per Share Annual)":"6.38","Book Value (Per Share Quarterly)":"6.58","Tangible Book Value (Per Share Annual)":"6.03","Tangible Book Value (Per Share Quarterly)":"6.23","Cash Per Share (Per Share Annual)":"8.66","Cash Per Share (Per Share Quarterly)":"8.71","Cash Flow (Per Share Annual)":"1.39","Cash Flow (Per Share TTM)":"--","Dividend (Per Share Annual)":"0.29","Dividends (Per Share TTM)":"0.29","EBITD (Per Share TTM)":"1.94","EPS Basic excl. Extra Items (Annual)":"1.05","EPS Basic excl. Extra Items (TTM)":"1.05","EPS incl. Extra Items (Annual)":"1.02","EPS incl. Extra Items (TTM)":"1.01","Free Cash Flow (Per Share TTM)":"-1.12","Dividend (Per Share 5Y)":"0.16"},"Valuation":{"P/E excl. Extra Items (Annual)":"5.23","P/E excl. Extra Items (TTM)":"5.27","P/E Normalized (Annual)":"4.87","Price to sales (Annual)":"0.41","Price to sales (TTM)":"0.42","Price to Tangible Book (Annual)":"0.89","Price to Tangible Book (Quarterly)":"0.86","Price to Free Cash Flow (Per Share Annual)":"--","Price to Cash Flow (Per Share TTM)":"--","Price to Free Cash Flow (Per Share TTM)":"--","Price to Book (Annual)":"0.84","Price to Book (Quarterly)":"0.81","P/E Basic excl. Extra Items (TTM)":"5.75","P/E excl. Extra Items High (TTM)":"31.59","P/E excl. Extra Items Low (TTM)":"5.62","P/E incl. Extra Items (TTM)":"5.27","Net Debt (Interim)":"40,898.31","Net Debt (Annual)":"43,213.51","Dividend Yield (5Y)":"2.12","Dividend Yield":"5.36","Current Dividend Yield (TTM)":"5.36"},"Financial Strength":{"Free Cash Flow (Annual)":"-2,678.38","Current Ratio (Annual)":"1.47","Net Interest coverage (Annual)":"14.63","Long Term Debt/Equity (Annual)":"188.86","Payout Ratio (Annual)":"27.27","Quick Ratio (Annual)":"0.44","Total Debt/Total Equity (Annual)":"360.63","Current EV/Free Cash Flow (Annual)":"--","Current EV/Free Cash Flow (TTM)":"--","Current Ratio (Quarterly)":"1.50","Long Term Debt/Equity (Quarterly)":"204.49","Quick Ratio (Quarterly)":"0.45","Total Debt/Total Equity (Quarterly)":"338.34","Free Cash Flow (TTM)":"-3,697.88","Net Interest Coverage (TTM)":"13.23","Payout Ratio (TTM)":"26.49"},"Margins":{"Gross Margin (Annual)":"24.54","Gross Margin (TTM)":"23.70","Net Profit Margin % (Annual)":"10.61","Net Profit Margin (TTM)":"10.68","Operating Margin (Annual)":"14.17","Operating Margin (TTM)":"14.35","Pretax Margin (TTM)":"14.43","Pretax Margin (Annual)":"14.26","Operating Margin (5Y)":"10.43","Pretax Margin (5Y)":"10.27","Free Operating Cash Flow/Revenue (5Y)":"-4.57","Free Operating Cash Flow/Revenue (TTM)":"-9.55","Gross Margin (5Y)":"22.29","Net Profit Margin (5Y)":"7.30"},"Management Effectiveness":{"Return on Assets (Annual)":"2.36","Return on Equity (TTM)":"2.25","Return on Average Equity (Annual)":"18.15","Return on Average equity (TTM)":"18.11","Return on Investment (Annual)":"7.33","Return on Investment (TTM)":"6.85","Return on Average Assets (5Y)":"1.94","Return on Average Equity (5Y)":"12.88","Return on Investment (5Y)":"5.42","Asset Turnover (Annual)":"0.22","Asset Turnover (TTM)":"0.21","Inventory Turnover (Annual)":"0.27","Inventory Turnover (TTM)":"0.25","Net Income/Employee (Annual)":"233,386.90","Net Income/Employee (TTM)":"238,016.40","Receivables Turnover (Annual)":"22.34","Receivables Turnover (TTM)":"19.43","Revenue/Employee (Annual)":"2,199,483.00","Revenue/Employee (TTM)":"2,229,145.00"},"Growth":{"Revenue Growth (Quarterly YoY)":"-7.90","Revenue Growth Rate (5Y)":"20.67","EPS Growth (Quarterly YoY)":"0.43","EPS Growth (TTM YoY)":"53.11","EPS Growth Rate (5Y)":"25.31","Dividend Growth Rate (3Y)":"58.98","Revenue Growth (TTM YoY)":"16.46","Revenue Growth (Per Share 5Y)":"16.74","Revenue Growth Rate (3Y)":"22.49","EPS Growth Rate (3Y)":"50.33","Book Value Growth Rate (Per Share 5Y)":"23.45","Tangible Book Value Total Equity CAGR (5Y)":"26.32","Capital Spending growth rate 5 year":"0.91","EBITDA CAGR (5Y)":"23.77","EBITDA Interim CAGR (5Y)":"23.19","Free Operating Cash Flow CAGR (5Y)":"--","Total Debt CAGR (5Y)":"29.51","Net Profit Margin Growth Rate (5Y)":"12.76"},"Income Statement":{"Revenue (Annual)":"39,193.68","Revenue (TTM)":"38,738.08","EBITD (Annual)":"6,466.15","EBITD (TTM)":"6,366.84","Earnings Before Taxes (Annual)":"5,590.48","Earnings Before Taxes (TTM)":"5,588.33","Net Income to Common (Annual)":"3,174.59","Net Income to Common (TTM)":"3,268.22","Earnings Before Taxes Normalized (Annual)":"5,905.46","Net Income Available to Common Normalized (Annual)":"3,408.91","Diluted Normalized EPS excl. Extra Items (TTM)":"1.10"}}}